Skip to main content
. 2023 Dec 12;13:22085. doi: 10.1038/s41598-023-49450-1

Figure 2.

Figure 2

Inhibition of CD38 NADase with anti-CD38 antibody ameliorated skin fibrosis. (A) Schematic of experimental design. C57/BL6 mice were pretreated with i.p. Ab68 or Ab69, followed by a 14-day course of daily bleomycin (BLM) subcutaneous injections alone, or combined with Ab68 or Ab69 (7–8 mice/group). Mice were sacrificed at day 21. (B) Schematic of Ab68 targeting CD38 NADase. Ab68 and Ab69 are heavy-chain antibodies with human VH domains and a silenced mouse IgG2a. Both antibodies bind mouse CD38, but only Ab68 inhibits the NAD+ hydrolase function of CD38. (C) Body weight. Each dot represents the result from a single mouse. (D) Lesional skin, trichrome stain, representative images, left panels (bar scale = 100 μm). Quantitation of dermis thickness and dermal white adipose tissue (dWAT). (E) Skin collagen content. (F) Gene expression in skin measured by qPCR. Results are means ± SEM from an experiment representative of two independent experiments; each dot represents the mean of triplicate determinations from each mouse.